The WASH study (Warfarin/Aspirin Study in Heart failure) rationale, design and end-points.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Works matching IS 13889842 AND DT 1999 AND VI 1 AND IP 1
Results: 20
1
2
Introduction.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 3
- By:
- Publication type:
- Article
3
Annotated references in epidemiology.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 101
- By:
- Publication type:
- Article
4
Is there a common mechanism of benefit for effective treatment of heart failure?
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 31
- By:
- Publication type:
- Article
5
Heart failure: why and how to define it?
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 7
- By:
- Publication type:
- Article
6
Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 25
- By:
- Publication type:
- Article
7
Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol. The Second Perspective Randomised study of Ibopamine on Mortality and Efficacy.
- Published in:
- 1999
- By:
- Publication type:
- journal article
8
Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure.
- Published in:
- 1999
- By:
- Publication type:
- journal article
9
Sudden death in heart failure: vascular or electrical?
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 41
- By:
- Publication type:
- Article
10
The WASH study (Warfarin/Aspirin Study in Heart failure) rationale, design and end-points.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 95
- Publication type:
- Article
11
Plasma brain natriuretic peptide--an independent predictor of cardiovascular mortality in acute heart failure.
- Published in:
- 1999
- By:
- Publication type:
- journal article
12
Surgical alternatives to transplantation for treatment of heart failure.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 47
- By:
- Publication type:
- Article
13
The role of arrhythmias in the progression of heart failure.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 35
- By:
- Publication type:
- Article
14
Update of recent clinical trials in heart failure and myocardial infarction.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 109
- By:
- Publication type:
- Article
15
Primary care physicians: champions of or an impediment to optimal care of the patient with heart failure?
- Published in:
- 1999
- By:
- Publication type:
- Editorial
16
Editor's note.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 1
- By:
- Publication type:
- Article
17
Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 73
- By:
- Publication type:
- Article
18
Novel approaches to retard ventricular remodeling in heart failure.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 17
- By:
- Publication type:
- Article
19
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 67
- By:
- Publication type:
- Article
20
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomes.
- Published in:
- European Journal of Heart Failure, 1999, v. 1, n. 1, p. 81
- By:
- Publication type:
- Article